These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Nuclear medicine imaging in pediatric oncology. Troncone L; Rufini V; Turba R; Mastrangelo R; Riccardi R; Donfrancesco F J Nucl Biol Med (1991); 1994 Mar; 38(1):76-84. PubMed ID: 8075180 [TBL] [Abstract][Full Text] [Related]
4. Presurgical diagnosis of a primary carcinoid tumor of the thymus with MIBG. Hirano T; Otake H; Watanabe N; Oriuchi N; Zennyouji A; Fukuda T; Endo K J Nucl Med; 1995 Dec; 36(12):2243-5. PubMed ID: 8523113 [TBL] [Abstract][Full Text] [Related]
5. [Scintigraphy using I 131 iodobenzylguanidine and malignant melanomas]. de Both PS; De Groot GH; Hoefnagel CA Ned Tijdschr Geneeskd; 1990 Oct; 134(42):2054-7. PubMed ID: 2234180 [TBL] [Abstract][Full Text] [Related]
10. Pitfall of Sipple's syndrome diagnosis by 131I-metaiodobenzylguanidine (MIBG). Talbot JN; Coutris G; Moulonguet M; Hoang C; Perniceni T; Milhaud G J Nucl Med Allied Sci; 1987; 31(4):337-40. PubMed ID: 2895168 [No Abstract] [Full Text] [Related]
11. 131I-MIBG scintigraphy in neural crest tumours. Samuel AM; Murugesan S; Kurkure PA; Advani SH; Sonawane GA; Noronha OP Indian J Cancer; 1994 Jun; 31(2):103-10. PubMed ID: 7927441 [TBL] [Abstract][Full Text] [Related]
12. 131I-metaiodobenzylguanidine (mIBG) for bronchial oat cell cancer and melanoma detection? Osei-Bonsu A; Kokoschka EM; Ulrich W; Sinzinger H Eur J Nucl Med; 1989; 15(9):629-31. PubMed ID: 2557215 [TBL] [Abstract][Full Text] [Related]
13. Scintigraphy and treatment of medullary carcinoma of the thyroid with iodine-131 metaiodobenzylguanidine. Clarke SE; Lazarus CR; Edwards S; Murby B; Clarke DG; Roden TM; Fogelman I; Maisey MN J Nucl Med; 1987 Dec; 28(12):1820-5. PubMed ID: 3681441 [TBL] [Abstract][Full Text] [Related]
14. 131I-MIBG and medullary carcinoma of the thyroid. Connell JM; Hilditch TE; Elliott A; Semple PF Lancet; 1984 Dec; 2(8414):1273-4. PubMed ID: 6150300 [No Abstract] [Full Text] [Related]
15. Imaging of medullary thyroid cancer with 131I-MIBG. Endo K; Shiomi K; Kasagi K; Konishi J; Torizuka K; Nakao K; Tanimura H Lancet; 1984 Jul; 2(8396):233. PubMed ID: 6146795 [No Abstract] [Full Text] [Related]
16. [The evaluation of 123I-MIBG scintigraphy in medullary thyroid carcinoma (MTC)]. Ahuja S; Koppenhagen K; Ernst H Strahlenther Onkol; 1990 Nov; 166(11):718-21. PubMed ID: 2260009 [TBL] [Abstract][Full Text] [Related]
17. The role of imaging tests in the diagnosis of thyroid carcinoma. Shulkin BL; Shapiro B Endocrinol Metab Clin North Am; 1990 Sep; 19(3):523-43. PubMed ID: 2175703 [TBL] [Abstract][Full Text] [Related]
18. Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma. Tenenbaum F; Lumbroso J; Schlumberger M; Mure A; Plouin PF; Caillou B; Parmentier C J Nucl Med; 1995 Jan; 36(1):1-6. PubMed ID: 7799058 [TBL] [Abstract][Full Text] [Related]